Generic drug
Carbamazepine price, strengths & recalls
Generic of Tegretol, Carbatrol, Equetro
Pharmacies pay $3.58 for 30 tablets of Carbamazepine 200 mg tablet this week, and from $3.58 to $39.88 across its 10 priced strengths and forms. 38 manufacturers make it. It is in shortage (being discontinued). 3 recalls are ongoing. Its official label last changed on September 14, 2026.
Being discontinued3 open recallsGeneric- Fair cash price
- $14.62
- Strengths
- 10
- Makers
- 38
- Updated
- Nov 11
Carbamazepine price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 mg chewable tablet | $0.2273 | $6.82 / 30 tablets |
| 200 mg chewable tablet | $1.19 | $35.71 / 30 tablets |
| 100 mg (12 hr) extended-release capsule | $1.09 | $32.80 / 30 capsules |
| 200 mg (12 hr) extended-release capsule | $1.03 | $30.98 / 30 capsules |
| 300 mg (12 hr) extended-release capsule | $1.13 | $33.95 / 30 capsules |
| 100 mg (12 hr) extended-release tablet | $0.1995 | $5.98 / 30 tablets |
| 200 mg (12 hr) extended-release tablet | $0.3794 | $11.38 / 30 tablets |
| 400 mg (12 hr) extended-release tablet | $0.7083 | $21.25 / 30 tablets |
| 20 mg/mL oral suspension | $0.0886 | $39.88 / 450 mL |
| 200 mg tablet | $0.1193 | $3.58 / 30 tablets |
The lowest cost per tablet is 200 mg tablet at $0.1193. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of carbamazepine
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 14 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Carbamazepine
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
Carbamazepine Tablets USP, (Chewable), 100 mg and 200 mg Carbamazepine Tablets USP, 200 mg Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg Carbamazepine Oral Suspension USP, 100 mg/5 mL
WARNINGS
SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE
APLASTIC ANEMIA AND AGRANULOCYTOSIS
APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF CARBAMAZEPINE. DATA FROM A POPULATION-BASED CASE CONTROL STUDY DEMONSTRATE THAT THE RISK OF DEVELOPING THESE REACTIONS IS 5 TO 8 TIMES GREATER THAN IN THE GENERAL POPULATION. HOWEVER, THE OVERALL RISK OF THESE REACTIONS IN THE UNTREATED GENERAL POPULATION IS LOW, APPROXIMATELY SIX PATIENTS PER ONE MILLION POPULATION PER YEAR FOR AGRANULOCYTOSIS AND TWO PATIENTS PER ONE MILLION POPULATION PER YEAR FOR APLASTIC ANEMIA.
ALTHOUGH REPORTS OF TRANSIENT OR PERSISTENT DECREASED PLATELET OR WHITE BLOOD CELL COUNTS ARE NOT UNCOMMON IN ASSOCIATION WITH THE USE OF CARBAMAZEPINE, DATA ARE NOT AVAILABLE TO ESTIMATE ACCURATELY THEIR INCIDENCE OR OUTCOME. HOWEVER, THE VAST MAJORITY OF THE CASES OF LEUKOPENIA HAVE NOT PROGRESSED TO THE MORE SERIOUS CONDITIONS OF APLASTIC ANEMIA OR AGRANULOCYTOSIS.
BECAUSE OF THE VERY LOW INCIDENCE OF AGRANULOCYTOSIS AND APLASTIC ANEMIA, THE VAST MAJORITY OF MINOR HEMATOLOGIC CHANGES OBSERVED IN MONITORING OF PATIENTS ON CARBAMAZEPINE ARE UNLIKELY TO SIGNAL THE OCCURRENCE OF EITHER ABNORMALITY. NONETHELESS, COMPLETE PRETREATMENT HEMATOLOGICAL TESTING SHOULD BE OBTAINED AS A BASELINE. IF A PATIENT IN THE COURSE OF TREATMENT EXHIBITS LOW OR DECREASED WHITE BLOOD CELL OR PLATELET COUNTS, THE PATIENT SHOULD BE MONITORED CLOSELY. DISCONTINUATION OF THE DRUG SHOULD BE CONSIDERED IF ANY EVIDENCE OF SIGNIFICANT BONE MARROW DEPRESSION DEVELOPS.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA020234 · Novartis
- First approved
- March 25, 1996 (30 years ago)
- Latest approved change
- July 15, 2026
- Approved label
- PDF, Jul 29, 2026
- Generic makers
- 26 approved generic applications on the market
Carbamazepine questions
How much does carbamazepine cost without insurance?
Pharmacies pay about $3.58 for 30 tablets of carbamazepine 200 mg tablet ($0.1193 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $14.62. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of carbamazepine?
Is carbamazepine in shortage?
Yes. 3 products are listed as in shortage or being discontinued (being discontinued). See which ones.
Has carbamazepine been recalled?
14 recalls on record, 3 ongoing. Recalls name specific lots - check yours.
When did the carbamazepine label last change?
The official label was last updated on September 14, 2026 (version 12). See what changed.
Talk about carbamazepine
No comments yet. Questions, tips, what worked for you - start the conversation.